Informations générales
140000639
8610Z
Autre Organisme Privé à But non Lucratif
14
Adresse
| 3 AV DU GENERAL HARRIS BP 5026 14076 CAEN CEDEX 5 | Accès au plan |
Listes des essais cliniques en recrutement
| Etude | Statut | Dernière mise à jour | |
|---|---|---|---|
| NCT03651206 | An International Multicentric Randomized Phase II Evaluating Dostarlimab in Combination With Niraparib Versus Niraparib Alone Compared to Chemotherapy in the Treatment of Metastatic or Recurrent Endometrial or Ovarian Carcinosarcoma After at Least One Line of Chemotherapy (ROCSAN) | 09 juillet 2025 | |
| NCT04767048 | Interest of Bilateral Basic Tongue Mucosectomy Assisted by Robot or Laser in Combination with Tonsillectomy in the Assessment of Prevalent Cervical Lymphadenopathy: a Randomized Phase II Study (RoboCUP) | 16 octobre 2024 | |
| NCT04299646 | A Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases (GETUG-StORM-01) | 10 août 2024 | |
| NCT03624244 | Randomized Comparative Prospective Multicentre Phase II Trial Evaluating Clinical Impact of Interruption VS Maintenance of AI in Patients with Locally Advanced/ Metastatic LGESS (BFR-ESS) | 02 septembre 2023 | |
| NCT04428554 | Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy: a Prospective Randomized Comparative Phase II Trial (BLAD-RAD01) | 04 août 2023 | |
| NCT04261192 | Establishment of Squamous Cell Organoids of the Head and Neck to Assess Their Response to Innovative Therapies (ORGAVADS) | 20 mars 2023 | |
| NCT03842982 | Phase III Randomized Clinical Trial Evaluating Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer Considering Two Different Settings: Primary Debulking Surgery (PDS) and Interval Debulking Surgery (IDS) (CHIPPI) | 20 mars 2023 | |
| NCT03831230 | Constitution of ex Vivo Ovarian Tumor Models for the Validation of the Interest of Innovative Therapies and the Search for Tumor or Circulating Biomarkers Predictive of Treatment Response (OVAREX) | 20 mars 2023 | |
| NCT03696680 | Stereotactic Radiotherapy for Cerebral Metastases with Recent Hemorrhagic Signal: Phase 2 Study in 2 Steps (STEREO-HBM) | 20 mars 2023 | |
| NCT03459235 | Assessment of Functional Digestive and Genitourinary Outcomes in Patients With Rectal Cancer Living After 2 Years Without Recurrence. Population Study. (Rectqol) (Rectqol) | 20 mars 2023 | |
| NCT03275311 | Epidemiological Strategy and Medical Economic (ESME) Research Program / Academic Real World Database: Evolution of the Therapeutic Care in Metastatic Breast Cancer Across the French Comprehensive Cancer Centers From 2008 (ESME-MBC) | 20 mars 2023 | |
| NCT03096041 | Phase 3 Study Randomized Against Placebo, Evaluating the Efficacy of Auriculotherapy in Patients With Musculoskeletal Pain by Aromatase Inhibitors in Adjuvant Treatment of Breast Cancer (TRIPLE-A) (TRIPLE-A) | 20 mars 2023 | |
| NCT03297723 | Effectiveness of a Patient Therapeutic Education Program in Improving Pain Management (EFFADOL-K) | 20 mars 2023 | |
| NCT04307277 | Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Soft Tissue Sarcoma (CHIC-STS01) | 20 mars 2023 | |
| NCT03848052 | Epidemiological Strategy and Medical Economic (ESME) Research Program / Academic Real World Data Platform: Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 | 05 novembre 2022 | |
| NCT00418743 | A Phase II Randomised Trial of Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC), Comparing Oral Combination Chemotherapy (CCNU, Cyclophosphamide, Etoposide) With Intravenous Association Chemotherapy. | 29 octobre 2022 |
Listes des établissements rattachés
| Finess | Etablissement | Catégorie | Adress |
|---|---|---|---|
| 140000555 | CRLCC FRANCOIS BACLESSE - CAEN | Centre de Lutte Contre Cancer | 3 AV DU GENERAL HARRIS BP 5026 14076 CAEN CEDEX 5 |
| 140030891 | UNITE RADIOTHERAPIE EXTERNE CFB | Centre de Lutte Contre Cancer | CITIS 35 ALL DE DAKAR 14200 HEROUVILLE ST CLAIR |
| 500021944 | UNITÉ RADIOTHÉRAPIE EXTERNE CHERBOURG | Centre de Lutte Contre Cancer | R DU TROTTEBEC BP 208 50100 CHERBOURG EN COTENTIN |